These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 4551336

  • 21. [Resistance testing of the pathogens in urinary tract infections on agar dip-slides].
    Büsser E, Binswanger U.
    Schweiz Med Wochenschr; 1973 Sep 15; 103(37):1294-7. PubMed ID: 4201354
    [No Abstract] [Full Text] [Related]

  • 22. Clinical implications. In vitro resistance of E coli to TMP/SMX.
    Postgrad Med; 2001 Aug 15; 110(2 Suppl):11-5; discussion 26-7. PubMed ID: 19667571
    [No Abstract] [Full Text] [Related]

  • 23. Distribution of integron-associated trimethoprim-sulfamethoxazole resistance determinants among Escherichia coli from humans and food-producing animals.
    Ho PL, Wong RC, Chow KH, Que TL.
    Lett Appl Microbiol; 2009 Nov 15; 49(5):627-34. PubMed ID: 19780962
    [Abstract] [Full Text] [Related]

  • 24. Transferable antibiotic resistance in Escherichia coli isolated from urinary-tract infections: hospital v. community patients.
    Rotimi VO, Emina PA, Eke PI.
    Afr J Med Med Sci; 1984 Nov 15; 13(1-2):47-53. PubMed ID: 6087639
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Risk factors for antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections: a prospective study.
    Sotto A, De Boever CM, Fabbro-Peray P, Gouby A, Sirot D, Jourdan J.
    J Clin Microbiol; 2001 Feb 15; 39(2):438-44. PubMed ID: 11158087
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [In vitro sensitivity of human pathogens to the drug combination sulfamethoxazole-trimethoprim].
    Lebek G, Wiedmer E.
    Schweiz Med Wochenschr; 1971 Sep 25; 101(38):1385-90. PubMed ID: 4946735
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. In vitro susceptibility of urinary pathogens to trimethoprim, nitrofurantoin and trimethoprim--nitrofurantoin combination.
    Anklesaria P, Paranjpe S, Gupta K, Acharya V, Paul T, Sheth UK.
    J Postgrad Med; 1976 Oct 25; 22(4):171-5. PubMed ID: 802242
    [No Abstract] [Full Text] [Related]

  • 34. Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.
    Lagacé-Wiens PR, Nichol KA, Nicolle LE, DeCorby M, McCracken M, Mulvey MR, Zhanel GG.
    J Antimicrob Chemother; 2006 Jun 25; 57(6):1262-3. PubMed ID: 16565157
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua.
    Matute AJ, Hak E, Schurink CA, McArthur A, Alonso E, Paniagua M, Van Asbeck E, Roskott AM, Froeling F, Rozenberg-Arska M, Hoepelman IM.
    Int J Antimicrob Agents; 2004 May 25; 23(5):506-9. PubMed ID: 15120732
    [Abstract] [Full Text] [Related]

  • 39. [Significance of continuous bacteriological control for the therapy of chronic urinary tract infections].
    Hensel K, Gruhn I, Schneider HJ, Klinger G.
    Z Urol Nephrol; 1974 Jul 25; 67(7):539-41. PubMed ID: 4613059
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.